Global PD-1 Antibody Drug Market Research Report 2024(Status and Outlook)
Report Overview
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
This report provides a deep insight into the global PD-1 Antibody Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 Antibody Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 Antibody Drug market in any manner.
Global PD-1 Antibody Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Thermo Fisher
InvivoGen
BioVision Inc.
Abcam
Bristol-Myers Squibb
Merck
Ono Pharmaceutical Co., Ltd
Eli Lilly
Chugai Pharmaceutical Co., Ltd
BeiGene
AbbVie
TG Therapeutics, Inc
Beijing Yiqiao Shenzhou Technology Co., Ltd.
3SBio
Market Segmentation (by Type)
Pembrolizumab
Nivolumab
Sindilimab
Toripalimab
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 Antibody Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
This report provides a deep insight into the global PD-1 Antibody Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 Antibody Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 Antibody Drug market in any manner.
Global PD-1 Antibody Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Thermo Fisher
InvivoGen
BioVision Inc.
Abcam
Bristol-Myers Squibb
Merck
Ono Pharmaceutical Co., Ltd
Eli Lilly
Chugai Pharmaceutical Co., Ltd
BeiGene
AbbVie
TG Therapeutics, Inc
Beijing Yiqiao Shenzhou Technology Co., Ltd.
3SBio
Market Segmentation (by Type)
Pembrolizumab
Nivolumab
Sindilimab
Toripalimab
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the PD-1 Antibody Drug Market
- Overview of the regional outlook of the PD-1 Antibody Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 Antibody Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PD-1 Antibody Drug
1.2 Key Market Segments
1.2.1 PD-1 Antibody Drug Segment by Type
1.2.2 PD-1 Antibody Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 ANTIBODY DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 Antibody Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 Antibody Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 ANTIBODY DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 Antibody Drug Sales by Manufacturers (2019-2024)
3.2 Global PD-1 Antibody Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 Antibody Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 Antibody Drug Sales Sites, Area Served, Product Type
3.6 PD-1 Antibody Drug Market Competitive Situation and Trends
3.6.1 PD-1 Antibody Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 Antibody Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 ANTIBODY DRUG INDUSTRY CHAIN ANALYSIS
4.1 PD-1 Antibody Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 ANTIBODY DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 ANTIBODY DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
6.3 Global PD-1 Antibody Drug Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 Antibody Drug Price by Type (2019-2024)
7 PD-1 ANTIBODY DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 Antibody Drug Market Sales by Application (2019-2024)
7.3 Global PD-1 Antibody Drug Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 Antibody Drug Sales Growth Rate by Application (2019-2024)
8 PD-1 ANTIBODY DRUG MARKET SEGMENTATION BY REGION
8.1 Global PD-1 Antibody Drug Sales by Region
8.1.1 Global PD-1 Antibody Drug Sales by Region
8.1.2 Global PD-1 Antibody Drug Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 Antibody Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 Antibody Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 Antibody Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 Antibody Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 Antibody Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis PD-1 Antibody Drug Basic Information
9.1.2 Novartis PD-1 Antibody Drug Product Overview
9.1.3 Novartis PD-1 Antibody Drug Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis PD-1 Antibody Drug SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Thermo Fisher
9.2.1 Thermo Fisher PD-1 Antibody Drug Basic Information
9.2.2 Thermo Fisher PD-1 Antibody Drug Product Overview
9.2.3 Thermo Fisher PD-1 Antibody Drug Product Market Performance
9.2.4 Thermo Fisher Business Overview
9.2.5 Thermo Fisher PD-1 Antibody Drug SWOT Analysis
9.2.6 Thermo Fisher Recent Developments
9.3 InvivoGen
9.3.1 InvivoGen PD-1 Antibody Drug Basic Information
9.3.2 InvivoGen PD-1 Antibody Drug Product Overview
9.3.3 InvivoGen PD-1 Antibody Drug Product Market Performance
9.3.4 InvivoGen PD-1 Antibody Drug SWOT Analysis
9.3.5 InvivoGen Business Overview
9.3.6 InvivoGen Recent Developments
9.4 BioVision Inc.
9.4.1 BioVision Inc. PD-1 Antibody Drug Basic Information
9.4.2 BioVision Inc. PD-1 Antibody Drug Product Overview
9.4.3 BioVision Inc. PD-1 Antibody Drug Product Market Performance
9.4.4 BioVision Inc. Business Overview
9.4.5 BioVision Inc. Recent Developments
9.5 Abcam
9.5.1 Abcam PD-1 Antibody Drug Basic Information
9.5.2 Abcam PD-1 Antibody Drug Product Overview
9.5.3 Abcam PD-1 Antibody Drug Product Market Performance
9.5.4 Abcam Business Overview
9.5.5 Abcam Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb PD-1 Antibody Drug Basic Information
9.6.2 Bristol-Myers Squibb PD-1 Antibody Drug Product Overview
9.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Merck
9.7.1 Merck PD-1 Antibody Drug Basic Information
9.7.2 Merck PD-1 Antibody Drug Product Overview
9.7.3 Merck PD-1 Antibody Drug Product Market Performance
9.7.4 Merck Business Overview
9.7.5 Merck Recent Developments
9.8 Ono Pharmaceutical Co., Ltd
9.8.1 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
9.8.2 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
9.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Market Performance
9.8.4 Ono Pharmaceutical Co., Ltd Business Overview
9.8.5 Ono Pharmaceutical Co., Ltd Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly PD-1 Antibody Drug Basic Information
9.9.2 Eli Lilly PD-1 Antibody Drug Product Overview
9.9.3 Eli Lilly PD-1 Antibody Drug Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 Chugai Pharmaceutical Co., Ltd
9.10.1 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
9.10.2 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
9.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Market Performance
9.10.4 Chugai Pharmaceutical Co., Ltd Business Overview
9.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments
9.11 BeiGene
9.11.1 BeiGene PD-1 Antibody Drug Basic Information
9.11.2 BeiGene PD-1 Antibody Drug Product Overview
9.11.3 BeiGene PD-1 Antibody Drug Product Market Performance
9.11.4 BeiGene Business Overview
9.11.5 BeiGene Recent Developments
9.12 AbbVie
9.12.1 AbbVie PD-1 Antibody Drug Basic Information
9.12.2 AbbVie PD-1 Antibody Drug Product Overview
9.12.3 AbbVie PD-1 Antibody Drug Product Market Performance
9.12.4 AbbVie Business Overview
9.12.5 AbbVie Recent Developments
9.13 TG Therapeutics, Inc
9.13.1 TG Therapeutics, Inc PD-1 Antibody Drug Basic Information
9.13.2 TG Therapeutics, Inc PD-1 Antibody Drug Product Overview
9.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Product Market Performance
9.13.4 TG Therapeutics, Inc Business Overview
9.13.5 TG Therapeutics, Inc Recent Developments
9.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
9.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Basic Information
9.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Overview
9.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Market Performance
9.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. Business Overview
9.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments
9.15 3SBio
9.15.1 3SBio PD-1 Antibody Drug Basic Information
9.15.2 3SBio PD-1 Antibody Drug Product Overview
9.15.3 3SBio PD-1 Antibody Drug Product Market Performance
9.15.4 3SBio Business Overview
9.15.5 3SBio Recent Developments
10 PD-1 ANTIBODY DRUG MARKET FORECAST BY REGION
10.1 Global PD-1 Antibody Drug Market Size Forecast
10.2 Global PD-1 Antibody Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 Antibody Drug Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 Antibody Drug Market Size Forecast by Region
10.2.4 South America PD-1 Antibody Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 Antibody Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 Antibody Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 Antibody Drug by Type (2025-2030)
11.1.2 Global PD-1 Antibody Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 Antibody Drug by Type (2025-2030)
11.2 Global PD-1 Antibody Drug Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 Antibody Drug Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 Antibody Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PD-1 Antibody Drug
1.2 Key Market Segments
1.2.1 PD-1 Antibody Drug Segment by Type
1.2.2 PD-1 Antibody Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 ANTIBODY DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 Antibody Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 Antibody Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 ANTIBODY DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 Antibody Drug Sales by Manufacturers (2019-2024)
3.2 Global PD-1 Antibody Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 Antibody Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 Antibody Drug Sales Sites, Area Served, Product Type
3.6 PD-1 Antibody Drug Market Competitive Situation and Trends
3.6.1 PD-1 Antibody Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 Antibody Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 ANTIBODY DRUG INDUSTRY CHAIN ANALYSIS
4.1 PD-1 Antibody Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 ANTIBODY DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 ANTIBODY DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
6.3 Global PD-1 Antibody Drug Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 Antibody Drug Price by Type (2019-2024)
7 PD-1 ANTIBODY DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 Antibody Drug Market Sales by Application (2019-2024)
7.3 Global PD-1 Antibody Drug Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 Antibody Drug Sales Growth Rate by Application (2019-2024)
8 PD-1 ANTIBODY DRUG MARKET SEGMENTATION BY REGION
8.1 Global PD-1 Antibody Drug Sales by Region
8.1.1 Global PD-1 Antibody Drug Sales by Region
8.1.2 Global PD-1 Antibody Drug Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 Antibody Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 Antibody Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 Antibody Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 Antibody Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 Antibody Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis PD-1 Antibody Drug Basic Information
9.1.2 Novartis PD-1 Antibody Drug Product Overview
9.1.3 Novartis PD-1 Antibody Drug Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis PD-1 Antibody Drug SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Thermo Fisher
9.2.1 Thermo Fisher PD-1 Antibody Drug Basic Information
9.2.2 Thermo Fisher PD-1 Antibody Drug Product Overview
9.2.3 Thermo Fisher PD-1 Antibody Drug Product Market Performance
9.2.4 Thermo Fisher Business Overview
9.2.5 Thermo Fisher PD-1 Antibody Drug SWOT Analysis
9.2.6 Thermo Fisher Recent Developments
9.3 InvivoGen
9.3.1 InvivoGen PD-1 Antibody Drug Basic Information
9.3.2 InvivoGen PD-1 Antibody Drug Product Overview
9.3.3 InvivoGen PD-1 Antibody Drug Product Market Performance
9.3.4 InvivoGen PD-1 Antibody Drug SWOT Analysis
9.3.5 InvivoGen Business Overview
9.3.6 InvivoGen Recent Developments
9.4 BioVision Inc.
9.4.1 BioVision Inc. PD-1 Antibody Drug Basic Information
9.4.2 BioVision Inc. PD-1 Antibody Drug Product Overview
9.4.3 BioVision Inc. PD-1 Antibody Drug Product Market Performance
9.4.4 BioVision Inc. Business Overview
9.4.5 BioVision Inc. Recent Developments
9.5 Abcam
9.5.1 Abcam PD-1 Antibody Drug Basic Information
9.5.2 Abcam PD-1 Antibody Drug Product Overview
9.5.3 Abcam PD-1 Antibody Drug Product Market Performance
9.5.4 Abcam Business Overview
9.5.5 Abcam Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb PD-1 Antibody Drug Basic Information
9.6.2 Bristol-Myers Squibb PD-1 Antibody Drug Product Overview
9.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Merck
9.7.1 Merck PD-1 Antibody Drug Basic Information
9.7.2 Merck PD-1 Antibody Drug Product Overview
9.7.3 Merck PD-1 Antibody Drug Product Market Performance
9.7.4 Merck Business Overview
9.7.5 Merck Recent Developments
9.8 Ono Pharmaceutical Co., Ltd
9.8.1 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
9.8.2 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
9.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Market Performance
9.8.4 Ono Pharmaceutical Co., Ltd Business Overview
9.8.5 Ono Pharmaceutical Co., Ltd Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly PD-1 Antibody Drug Basic Information
9.9.2 Eli Lilly PD-1 Antibody Drug Product Overview
9.9.3 Eli Lilly PD-1 Antibody Drug Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 Chugai Pharmaceutical Co., Ltd
9.10.1 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
9.10.2 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
9.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Market Performance
9.10.4 Chugai Pharmaceutical Co., Ltd Business Overview
9.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments
9.11 BeiGene
9.11.1 BeiGene PD-1 Antibody Drug Basic Information
9.11.2 BeiGene PD-1 Antibody Drug Product Overview
9.11.3 BeiGene PD-1 Antibody Drug Product Market Performance
9.11.4 BeiGene Business Overview
9.11.5 BeiGene Recent Developments
9.12 AbbVie
9.12.1 AbbVie PD-1 Antibody Drug Basic Information
9.12.2 AbbVie PD-1 Antibody Drug Product Overview
9.12.3 AbbVie PD-1 Antibody Drug Product Market Performance
9.12.4 AbbVie Business Overview
9.12.5 AbbVie Recent Developments
9.13 TG Therapeutics, Inc
9.13.1 TG Therapeutics, Inc PD-1 Antibody Drug Basic Information
9.13.2 TG Therapeutics, Inc PD-1 Antibody Drug Product Overview
9.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Product Market Performance
9.13.4 TG Therapeutics, Inc Business Overview
9.13.5 TG Therapeutics, Inc Recent Developments
9.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
9.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Basic Information
9.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Overview
9.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Market Performance
9.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. Business Overview
9.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments
9.15 3SBio
9.15.1 3SBio PD-1 Antibody Drug Basic Information
9.15.2 3SBio PD-1 Antibody Drug Product Overview
9.15.3 3SBio PD-1 Antibody Drug Product Market Performance
9.15.4 3SBio Business Overview
9.15.5 3SBio Recent Developments
10 PD-1 ANTIBODY DRUG MARKET FORECAST BY REGION
10.1 Global PD-1 Antibody Drug Market Size Forecast
10.2 Global PD-1 Antibody Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 Antibody Drug Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 Antibody Drug Market Size Forecast by Region
10.2.4 South America PD-1 Antibody Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 Antibody Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 Antibody Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 Antibody Drug by Type (2025-2030)
11.1.2 Global PD-1 Antibody Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 Antibody Drug by Type (2025-2030)
11.2 Global PD-1 Antibody Drug Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 Antibody Drug Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 Antibody Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 Antibody Drug Market Size Comparison by Region (M USD)
Table 5. Global PD-1 Antibody Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 Antibody Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 Antibody Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 Antibody Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 Antibody Drug as of 2022)
Table 10. Global Market PD-1 Antibody Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 Antibody Drug Sales Sites and Area Served
Table 12. Manufacturers PD-1 Antibody Drug Product Type
Table 13. Global PD-1 Antibody Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 Antibody Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 Antibody Drug Market Challenges
Table 22. Global PD-1 Antibody Drug Sales by Type (Kilotons)
Table 23. Global PD-1 Antibody Drug Market Size by Type (M USD)
Table 24. Global PD-1 Antibody Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 Antibody Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 Antibody Drug Market Size Share by Type (2019-2024)
Table 28. Global PD-1 Antibody Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 Antibody Drug Sales (Kilotons) by Application
Table 30. Global PD-1 Antibody Drug Market Size by Application
Table 31. Global PD-1 Antibody Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 Antibody Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 Antibody Drug Market Share by Application (2019-2024)
Table 35. Global PD-1 Antibody Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 Antibody Drug Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis PD-1 Antibody Drug Basic Information
Table 44. Novartis PD-1 Antibody Drug Product Overview
Table 45. Novartis PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis PD-1 Antibody Drug SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Thermo Fisher PD-1 Antibody Drug Basic Information
Table 50. Thermo Fisher PD-1 Antibody Drug Product Overview
Table 51. Thermo Fisher PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Business Overview
Table 53. Thermo Fisher PD-1 Antibody Drug SWOT Analysis
Table 54. Thermo Fisher Recent Developments
Table 55. InvivoGen PD-1 Antibody Drug Basic Information
Table 56. InvivoGen PD-1 Antibody Drug Product Overview
Table 57. InvivoGen PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. InvivoGen PD-1 Antibody Drug SWOT Analysis
Table 59. InvivoGen Business Overview
Table 60. InvivoGen Recent Developments
Table 61. BioVision Inc. PD-1 Antibody Drug Basic Information
Table 62. BioVision Inc. PD-1 Antibody Drug Product Overview
Table 63. BioVision Inc. PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. BioVision Inc. Business Overview
Table 65. BioVision Inc. Recent Developments
Table 66. Abcam PD-1 Antibody Drug Basic Information
Table 67. Abcam PD-1 Antibody Drug Product Overview
Table 68. Abcam PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Abcam Business Overview
Table 70. Abcam Recent Developments
Table 71. Bristol-Myers Squibb PD-1 Antibody Drug Basic Information
Table 72. Bristol-Myers Squibb PD-1 Antibody Drug Product Overview
Table 73. Bristol-Myers Squibb PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Merck PD-1 Antibody Drug Basic Information
Table 77. Merck PD-1 Antibody Drug Product Overview
Table 78. Merck PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Merck Business Overview
Table 80. Merck Recent Developments
Table 81. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
Table 82. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
Table 83. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Ono Pharmaceutical Co., Ltd Business Overview
Table 85. Ono Pharmaceutical Co., Ltd Recent Developments
Table 86. Eli Lilly PD-1 Antibody Drug Basic Information
Table 87. Eli Lilly PD-1 Antibody Drug Product Overview
Table 88. Eli Lilly PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
Table 92. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
Table 93. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Chugai Pharmaceutical Co., Ltd Business Overview
Table 95. Chugai Pharmaceutical Co., Ltd Recent Developments
Table 96. BeiGene PD-1 Antibody Drug Basic Information
Table 97. BeiGene PD-1 Antibody Drug Product Overview
Table 98. BeiGene PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. BeiGene Business Overview
Table 100. BeiGene Recent Developments
Table 101. AbbVie PD-1 Antibody Drug Basic Information
Table 102. AbbVie PD-1 Antibody Drug Product Overview
Table 103. AbbVie PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. AbbVie Business Overview
Table 105. AbbVie Recent Developments
Table 106. TG Therapeutics, Inc PD-1 Antibody Drug Basic Information
Table 107. TG Therapeutics, Inc PD-1 Antibody Drug Product Overview
Table 108. TG Therapeutics, Inc PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. TG Therapeutics, Inc Business Overview
Table 110. TG Therapeutics, Inc Recent Developments
Table 111. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Basic Information
Table 112. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Overview
Table 113. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Beijing Yiqiao Shenzhou Technology Co., Ltd. Business Overview
Table 115. Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments
Table 116. 3SBio PD-1 Antibody Drug Basic Information
Table 117. 3SBio PD-1 Antibody Drug Product Overview
Table 118. 3SBio PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. 3SBio Business Overview
Table 120. 3SBio Recent Developments
Table 121. Global PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global PD-1 Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific PD-1 Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa PD-1 Antibody Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global PD-1 Antibody Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global PD-1 Antibody Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global PD-1 Antibody Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global PD-1 Antibody Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global PD-1 Antibody Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 Antibody Drug Market Size Comparison by Region (M USD)
Table 5. Global PD-1 Antibody Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 Antibody Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 Antibody Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 Antibody Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 Antibody Drug as of 2022)
Table 10. Global Market PD-1 Antibody Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 Antibody Drug Sales Sites and Area Served
Table 12. Manufacturers PD-1 Antibody Drug Product Type
Table 13. Global PD-1 Antibody Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 Antibody Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 Antibody Drug Market Challenges
Table 22. Global PD-1 Antibody Drug Sales by Type (Kilotons)
Table 23. Global PD-1 Antibody Drug Market Size by Type (M USD)
Table 24. Global PD-1 Antibody Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 Antibody Drug Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 Antibody Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 Antibody Drug Market Size Share by Type (2019-2024)
Table 28. Global PD-1 Antibody Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 Antibody Drug Sales (Kilotons) by Application
Table 30. Global PD-1 Antibody Drug Market Size by Application
Table 31. Global PD-1 Antibody Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 Antibody Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 Antibody Drug Market Share by Application (2019-2024)
Table 35. Global PD-1 Antibody Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 Antibody Drug Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis PD-1 Antibody Drug Basic Information
Table 44. Novartis PD-1 Antibody Drug Product Overview
Table 45. Novartis PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis PD-1 Antibody Drug SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Thermo Fisher PD-1 Antibody Drug Basic Information
Table 50. Thermo Fisher PD-1 Antibody Drug Product Overview
Table 51. Thermo Fisher PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Business Overview
Table 53. Thermo Fisher PD-1 Antibody Drug SWOT Analysis
Table 54. Thermo Fisher Recent Developments
Table 55. InvivoGen PD-1 Antibody Drug Basic Information
Table 56. InvivoGen PD-1 Antibody Drug Product Overview
Table 57. InvivoGen PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. InvivoGen PD-1 Antibody Drug SWOT Analysis
Table 59. InvivoGen Business Overview
Table 60. InvivoGen Recent Developments
Table 61. BioVision Inc. PD-1 Antibody Drug Basic Information
Table 62. BioVision Inc. PD-1 Antibody Drug Product Overview
Table 63. BioVision Inc. PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. BioVision Inc. Business Overview
Table 65. BioVision Inc. Recent Developments
Table 66. Abcam PD-1 Antibody Drug Basic Information
Table 67. Abcam PD-1 Antibody Drug Product Overview
Table 68. Abcam PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Abcam Business Overview
Table 70. Abcam Recent Developments
Table 71. Bristol-Myers Squibb PD-1 Antibody Drug Basic Information
Table 72. Bristol-Myers Squibb PD-1 Antibody Drug Product Overview
Table 73. Bristol-Myers Squibb PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Merck PD-1 Antibody Drug Basic Information
Table 77. Merck PD-1 Antibody Drug Product Overview
Table 78. Merck PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Merck Business Overview
Table 80. Merck Recent Developments
Table 81. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
Table 82. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
Table 83. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Ono Pharmaceutical Co., Ltd Business Overview
Table 85. Ono Pharmaceutical Co., Ltd Recent Developments
Table 86. Eli Lilly PD-1 Antibody Drug Basic Information
Table 87. Eli Lilly PD-1 Antibody Drug Product Overview
Table 88. Eli Lilly PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Basic Information
Table 92. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product Overview
Table 93. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Chugai Pharmaceutical Co., Ltd Business Overview
Table 95. Chugai Pharmaceutical Co., Ltd Recent Developments
Table 96. BeiGene PD-1 Antibody Drug Basic Information
Table 97. BeiGene PD-1 Antibody Drug Product Overview
Table 98. BeiGene PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. BeiGene Business Overview
Table 100. BeiGene Recent Developments
Table 101. AbbVie PD-1 Antibody Drug Basic Information
Table 102. AbbVie PD-1 Antibody Drug Product Overview
Table 103. AbbVie PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. AbbVie Business Overview
Table 105. AbbVie Recent Developments
Table 106. TG Therapeutics, Inc PD-1 Antibody Drug Basic Information
Table 107. TG Therapeutics, Inc PD-1 Antibody Drug Product Overview
Table 108. TG Therapeutics, Inc PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. TG Therapeutics, Inc Business Overview
Table 110. TG Therapeutics, Inc Recent Developments
Table 111. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Basic Information
Table 112. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product Overview
Table 113. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Beijing Yiqiao Shenzhou Technology Co., Ltd. Business Overview
Table 115. Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments
Table 116. 3SBio PD-1 Antibody Drug Basic Information
Table 117. 3SBio PD-1 Antibody Drug Product Overview
Table 118. 3SBio PD-1 Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. 3SBio Business Overview
Table 120. 3SBio Recent Developments
Table 121. Global PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global PD-1 Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific PD-1 Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific PD-1 Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America PD-1 Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa PD-1 Antibody Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa PD-1 Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global PD-1 Antibody Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global PD-1 Antibody Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global PD-1 Antibody Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global PD-1 Antibody Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global PD-1 Antibody Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PD-1 Antibody Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 Antibody Drug Market Size (M USD), 2019-2030
Figure 5. Global PD-1 Antibody Drug Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 Antibody Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 Antibody Drug Market Size by Country (M USD)
Figure 11. PD-1 Antibody Drug Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 Antibody Drug Revenue Share by Manufacturers in 2023
Figure 13. PD-1 Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 Antibody Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 Antibody Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 Antibody Drug Market Share by Type
Figure 18. Sales Market Share of PD-1 Antibody Drug by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 Antibody Drug by Type in 2023
Figure 20. Market Size Share of PD-1 Antibody Drug by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 Antibody Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 Antibody Drug Market Share by Application
Figure 24. Global PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 Antibody Drug Sales Market Share by Application in 2023
Figure 26. Global PD-1 Antibody Drug Market Share by Application (2019-2024)
Figure 27. Global PD-1 Antibody Drug Market Share by Application in 2023
Figure 28. Global PD-1 Antibody Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 Antibody Drug Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 Antibody Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 Antibody Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 37. Germany PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 Antibody Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 Antibody Drug Sales Market Share by Region in 2023
Figure 44. China PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 Antibody Drug Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 Antibody Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 Antibody Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 Antibody Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 Antibody Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 Antibody Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 Antibody Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 Antibody Drug Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 Antibody Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of PD-1 Antibody Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 Antibody Drug Market Size (M USD), 2019-2030
Figure 5. Global PD-1 Antibody Drug Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 Antibody Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 Antibody Drug Market Size by Country (M USD)
Figure 11. PD-1 Antibody Drug Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 Antibody Drug Revenue Share by Manufacturers in 2023
Figure 13. PD-1 Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 Antibody Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 Antibody Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 Antibody Drug Market Share by Type
Figure 18. Sales Market Share of PD-1 Antibody Drug by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 Antibody Drug by Type in 2023
Figure 20. Market Size Share of PD-1 Antibody Drug by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 Antibody Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 Antibody Drug Market Share by Application
Figure 24. Global PD-1 Antibody Drug Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 Antibody Drug Sales Market Share by Application in 2023
Figure 26. Global PD-1 Antibody Drug Market Share by Application (2019-2024)
Figure 27. Global PD-1 Antibody Drug Market Share by Application in 2023
Figure 28. Global PD-1 Antibody Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 Antibody Drug Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 Antibody Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 Antibody Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 37. Germany PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 Antibody Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 Antibody Drug Sales Market Share by Region in 2023
Figure 44. China PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 Antibody Drug Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 Antibody Drug Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 Antibody Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 Antibody Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 Antibody Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 Antibody Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 Antibody Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 Antibody Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 Antibody Drug Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 Antibody Drug Market Share Forecast by Application (2025-2030)
